Zhu Yuxi
7PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Feb 10, 2022
The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC.Zhi Wang, Lingling Zhang, Wenwen Xu
|Sep 27, 2021
PD-1/PD-L1 Inhibitors versus Chemotherapy for Previously Treated Advanced Gastroesophageal Cancer: A Meta-Analysis of Randomized Controlled Trials.Zhong Maoxi, Xue Jinmin, Zeng Xiaozhu
|Sep 20, 2021
A Comprehensive Multiomics Analysis Identified Ubiquilin 4 as a Promising Prognostic Biomarker of Immune-Related Therapy in Pan-Cancer.Jie Li, Ye Tong, Zhi Wang
|Jun 14, 2021
Combination of the EP and Anti-PD-1 Pathway or Anti-CTLA-4 for the Phase III Trial of Small-Cell Lung Cancer: A Meta-Analysis.Abdulhakim A A Abunasser, Jinmin Xue, Ehab J A Balawi
|Feb 25, 2021
Down-regulation of RCC1 sensitizes immunotherapy by up-regulating PD-L1 via p27kip1 /CDK4 axis in non-small cell lung cancer.Xiaozhu Zeng, Maoxi Zhong, Yumeng Yang
|May 16, 2020
Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions.Xiaozhu Zeng, Linghong Wan, Yu Wang
Pageof 2
